ALBUTEROL\AMBROXOL\GUAIFENESIN: 40 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
40
Total FAERS Reports
0
Deaths Reported
34
Hospitalizations
40
As Primary/Secondary Suspect
16
Life-Threatening
Active Ingredient: ALBUTEROL SULFATE\AMBROXOL HYDROCHLORIDE\GUAIFENESIN ·
What Are the Most Common ALBUTEROL\AMBROXOL\GUAIFENESIN Side Effects?
#1 Most Reported
Toxicity to various agents
28 reports (70.0%)
#2 Most Reported
Sedation complication
28 reports (70.0%)
#3 Most Reported
Sedation
28 reports (70.0%)
All ALBUTEROL\AMBROXOL\GUAIFENESIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Balance disorder | 28 | 70.0% | 0 | 28 |
| Blood calcium decreased | 28 | 70.0% | 0 | 28 |
| Cognitive disorder | 28 | 70.0% | 0 | 28 |
| Constipation | 28 | 70.0% | 0 | 28 |
| Creatinine renal clearance decreased | 28 | 70.0% | 0 | 28 |
| Depressed level of consciousness | 28 | 70.0% | 0 | 28 |
| Fall | 28 | 70.0% | 0 | 28 |
| Hypotension | 28 | 70.0% | 0 | 28 |
| Mobility decreased | 28 | 70.0% | 0 | 28 |
| Orthostatic hypotension | 28 | 70.0% | 0 | 28 |
| Pain | 28 | 70.0% | 0 | 28 |
| Sedation | 28 | 70.0% | 0 | 28 |
| Sedation complication | 28 | 70.0% | 0 | 28 |
| Toxicity to various agents | 28 | 70.0% | 0 | 28 |
| Dyspnoea | 23 | 57.5% | 0 | 20 |
| Multiple drug therapy | 16 | 40.0% | 0 | 16 |
| Drug interaction | 15 | 37.5% | 0 | 15 |
| Renal function test abnormal | 15 | 37.5% | 0 | 15 |
| Asthma | 12 | 30.0% | 0 | 6 |
| Product use in unapproved indication | 12 | 30.0% | 0 | 12 |
Who Reports ALBUTEROL\AMBROXOL\GUAIFENESIN Side Effects? Age & Gender Data
Gender: 97.3% female, 2.7% male. Average age: 73.2 years. Most reports from: CA. View detailed demographics →
What Is ALBUTEROL\AMBROXOL\GUAIFENESIN Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 38 |
Official FDA Label for ALBUTEROL\AMBROXOL\GUAIFENESIN
Official prescribing information from the FDA-approved drug label.